Skip to content
Search

Latest Stories

Indian pharma exports soaring despite cough syrup deaths

The robust forecast comes despite last year’s deaths of dozens of children in Gambia, which the WHO linked to drugs made in India

Indian pharma exports soaring despite cough syrup deaths

INDIA'S pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong US buying, a government-backed trade body said, despite deaths linked to Indian-made cough syrups.

The robust forecast comes against the backdrop of earlier concerns from the government that last year's deaths of dozens of children in Gambia, which the World Health Organization (WHO) linked to drugs made in India, had "adversely impacted the image of India's pharmaceutical products across the globe".

Two other cough syrups made in India killed 19 children in Uzbekistan around December, according to the Uzbekistan government.

India is the world's third largest maker of drugs by volume after the United States and China, and senior pharma trade official Udaya Bhaskar said the country was too big a player for buyers to move away because of "these aberrations" in Gambia and Uzbekistan.

"As far as the Gambia and Uzbekistan incidents are concerned, if you see in terms of the image of the country, there is a dent," Bhaskar, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), said on Tuesday (25).

"But if you see our (April-June) exports, they have grown. We are doing very well in the US market, we are growing at more than 10 per cent there. In the past four-five months, the growth in exports shows that people have not taken very, very seriously (any concerns about) the quality of Indian pharmaceuticals."

India's pharma exports rose 3.25 per cent in the year to March 31 to $25.4 bn and Bhaskar said it was set to grow by about 6.3 per cent to $27 bn this fiscal year.

Sales to the United States, India's biggest market with 30 per cent of its overall pharma exports, rose 6.2 per cent to $7.5 bn last fiscal year, government data show.

India's overall pharma exports in the April-June quarter rose five per cent to $6.58 bn.

India is seeing good overall demand for drugs for central nervous system conditions, cardiovascular and oncology, Bhaskar said.

Country visits

Pharmexcil delegations have visited countries including Nigeria, Egypt and Russia in recent months to allay any concerns about Indian drugs, he said.

"Wherever we are going, people are asking and we are clarifying," Bhaskar said. "We are telling them our stand. We are trying our level best."

India has denied links to the deaths in Gambia but found another company guilty of sending adulterated products to Uzbekistan and cancelled its licence. The company, Marion Biotech, has denied wrongdoing.

Gambia has made it mandatory for all Indian drugs to be tested before being exported to the African country since July 1. India has since June 1 made it compulsory for all cough syrups to be tested before export.

But India's cough syrup exports, including those made by drugmakers that follow the traditional Indian method of Ayurveda, are only about $15 million a year and exports have largely remained intact, Bhaskar said.

Apart from Gambia, no other country has asked for additional tests for Indian drugs since the deaths, he said.

"Whatever exports we are doing to countries like the US, our largest importer, they are not asking. There are so many countries we are exporting to, the UK, South Africa, Brazil or any other market. They are not asking."

Manufacturing a drug in Europe or the United States costs more than 30 per cent than in India, giving India a big advantage, he said.

"India is known for producing quality drugs at an affordable price," he said. "That is the major advantage for India and we are enjoying that for the last 15-20 years."

Russia sales dip


India's exports to Russia, however, have suffered because of the Ukraine war. Sales to the country fell 4.2 per cent last fiscal year to $573m, according to government data, taking Russia to the seventh position from fourth among India's biggest pharma importers. Russia's share in India's pharma exports is generally around 2.5 per cent but has now dipped to 2.2 per cent.

Since Russia invaded Ukraine on February 24 last year and until June 5 this year, India's pharma exports to Russia fell 4.6 per cent to about $691 million from the corresponding period a year earlier, a government source said.

Bhaskar said the fall could be due to a dollar shortage for Russia, its attempts to prop up the domestic market and some reluctance among big Indian companies to do too much business with it while also trading with the United States, even though there are no Western sanctions on pharma products.

(Reuters)

More For You

Trump Mobile

President Trump reported earning over $8 million in 2024 from various licensing agreements

Getty Images

Trump Mobile introduces $499 device bundled with $47 unlimited talk, text and data plan

The Trump Organization has announced the launch of Trump Mobile, a branded mobile phone service and a $499 smartphone, both expected to debut in September 2025. This marks the latest in a growing list of commercial ventures associated with President Donald Trump.

The 47 Plan: patriotic branding and telecoms offering

Trump Mobile’s service package, dubbed The 47 Plan, will cost $47.45 per month and include unlimited calls, texts, and data. Customers will also receive roadside assistance and access to a “Telehealth and Pharmacy Benefit”. Both the name and pricing of the plan are symbolic, referencing Trump’s political position as the 47th president of the United States.

Keep ReadingShow less
Madhvani group executives meet Modi to discuss investments in India

Madhvani Group executives with Narendra Modi

Madhvani group executives meet Modi to discuss investments in India

Executives from the Madhvani Group, including Shrai Madhvani, his wife Aparna Madhvani, and director Nitin Gadhia, met Indian Prime Minister Narendra Modi at his official residence in New Delhi on Saturday to discuss the group’s proposed investments in India, including the acquisition of Hindustan National Glass Ltd (HNGIL).

The meeting focused on the group's plans to invest in India through INSCO, which is seeking to acquire HNGIL, the country’s largest container glass manufacturer. The acquisition is currently awaiting approval from the National Company Law Tribunal (NCLT), following key rulings by the Supreme Court of India on January 29 and May 16, 2025.

Keep ReadingShow less
Apple India Reroutes 97% of iPhones to US Amid Tariff Push

Apple iPhones are seen inside India's first Apple retail store in Mumbai, India, April 17, 2023.

REUTERS

Foxconn sends 97 per cent of India iPhone exports to US amid tariff push

NEARLY all iPhones exported by Foxconn from India between March and May were shipped to the United States, according to customs data reviewed by Reuters.

The data showed that 97 per cent of Foxconn’s iPhone exports during this period went to the US, significantly higher than the 2024 average of 50.3 per cent.

Keep ReadingShow less
Weaker labour market data sparks debate on rate cuts

The Bank of England is weighing inflation signals ahead of rate call

Weaker labour market data sparks debate on rate cuts

PAY growth in Britain slowed sharply and unemployment rose to its highest level in nearly four years in the three months to April, official figures showed on Tuesday (10), potentially reducing the Bank of England’s (BoE) caution over further interest rate cuts.

Wage growth excluding bonuses slowed to 5.2 per cent, the weakest pace since the three months to September, and fell more than expected from 5.5 per cent in January to March this year.

Keep ReadingShow less
London Tech Week: Indian firms show investment intent

Keir Starmer at London Tech Week in London on Monday (9)

London Tech Week: Indian firms show investment intent

MORE THAN 350 technology companies from India joined London Tech Week, which began on Monday – making it the largest-ever delegation from the country to attend the event.

London mayor Sadiq Khan’s office, City Hall, described the rise in Indian participation as a reflection of deepening ties between India and London’s tech sectors, following the recent signing of the India– UK Free Trade Agreement (FTA).

Keep ReadingShow less